Measurement of red cell lifespan and aging

Transfusion Medicine and Hemotherapy

Volumn 39, Issue 5, 2012, Pages 302-307

  Franco, Robert S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Biotin; Chromium; Red cell aging; Red cell lifespan; Red cell senescence

Indexed keywords

BIOTIN; CARBON MONOXIDE; CHROMIUM 51; GLYCINE; HEMOGLOBIN;

BLOOD TRANSFUSION; CELL AGING; CELL SURVIVAL; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; IN VIVO STUDY; ISOLATION PROCEDURE; MEASUREMENT; PRECURSOR; REVIEW; TURNOVER TIME;

EID: 84867019241     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000342232     Document Type: Review

References (47)

1. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH: Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284-4291.
2. Mock DM, Matthews NI, Zhu S, Strauss RG, Schmidt RL, Nalbant D, Cress GA, Widness JA: Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. Transfusion 2011;51:1047-1057.
3. Ashby W: The determination of the length of life of transfused blood corpuscles in man. J Exp Med 1919;29:267-281.
4. Franco RS: The measurement and importance of red cell survival. Am J Hematol 2009;84:109-114.
5. Mollison PL: Blood-group antibodies and red-cell destruction. Br Med J 1959;2:1123-1130.
6. Mollison PL, Engelfriet CP, Contreras M: The Transfusion of Red Cells; Blood Transfusion in Clinical Medicine. Oxford, Blackwell, 1987, pp 95-159.
7. Dumont LJ, AuBuchon JP: Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008; 48:1053-1060.
8. Wang D, Sun J, Solomon SB, Klein HG, Natanson C: Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012;52:1184-1195.
9. Willekens FL, Bosch FH, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, Werre JM: Quantification of loss of haemoglobin components from the circulating red blood cell in vivo. Eur J Haematol 1997;58:246-250.
10. Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, Bos HJ, Bosman GJ, van den Bos AG, Verkleij AJ, Werre JM: Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 2003;101:747-751.
11. Klein HG, Anstee DJ: Appendix 2 and Appendix 6; Blood Transfusion in Clinical Medicine. Malden, MA, Blackwell, 2005, pp 846-850.
12. Recommended methods for radioisotope red-cell survival studies. A report by the ICSH panel on diagnostic applications of radioisotopes in haematology. Br J Haematol 1971;21:241-250.
13. International Committee for Standardization in Haematology: Recommended method for radioisotope red-cell survival studies. Br J Haematol 1980; 45:659-666.
14. Garby L, Mollison PL: Deduction of mean red-cell life-span from 51Cr survival curves. Br J Haematol 1971;20:527-536.
15. Bentley SA, Glass HI, Lewis SM, Szur L: Elution correction in 51Cr red cell survival studies. Br J Haematol 1974;26:179-184.
16. Valeri CR, Kuehl GV, Skrabut EM, Bechthold DA, Vecchione JJ, Harkness DR, EMERSON CP: Studies on the in vivo elution of 51Cr from baboon red blood cells. Vox Sang 1981;40:338-345.
17. Strauss RG, Mock DM, Widness JA, Johnson K, Cress G, Schmidt RL: Posttransfusion 24-hour recovery and subsequent survival of allogeneic red blood cells in the bloodstream of newborn infants. Transfusion 2004;44:871-876.
18. Mock DM, Lankford GL, Widness JA, Burmeister LF, Kahn D, Strauss RG: Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion 1999;39: 156-162.
19. Franco RS, Lohmann J, Silberstein EB, Mayfield-Pratt G, Palascak M, Nemeth TA, Joiner CH, Weiner M, Rucknagel DL: Time-dependent changes in the density and hemoglobin F content of biotinlabeled sickle cells. J Clin Invest 1998;101:2730-2740.
20. Franco RS, Yasin Z, Palascak MB, Ciraolo P, Joiner CH, Rucknagel DL: The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood 2006;108:1073-1076.
21. Yasin Z, Witting S, Palascak MB, Joiner CH, Rucknagel DL, Franco RS: Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 2003;102:365-370.
22. Franco RS, Yasin Z, Lohmann JM, Palascak MB, Nemeth TA, Weiner M, Joiner CH, Rucknagel DL: The survival characteristics of dense sickle cells. Blood 2000;96:3610-3617.
23. Cordle DG, Strauss RG, Lankford G, Mock DM: Antibodies provoked by the transfusion of biotinlabeled red cells. Transfusion 1999;39:1065-1069.
24. Coburn RF, Blakemore WS, Forster RE: Endogenous carbon monoxide production in man. J Clin Invest 1963;42:1172-1178.
25. Coburn RF, Williams WJ, Kahn SB: Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest 1966;45:460-468.
26. White P, Coburn RF, Williams WJ, Goldwein MI, Rother ML, Shafer BC: Carbon monoxide production associated with ineffective erythropoiesis. J Clin Invest 1967;46:1986-1998.
27. Coburn RF: Endogenous carbon monoxide production. N Engl J Med 1970;282:207-209.
28. Coburn RF: Endogenous carbon monoxide metabolism. Annu Rev Med 1973;24:241-250.
29. Furne JK, Springfield JR, Ho SB, Levitt MD: Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 2003;142:52-57.
30. Mitlyng BL, Chandrashekhar Y, Furne JK, Levitt MD: Use of breath carbon monoxide to measure the influence of prosthetic heart valves on erythrocyte survival. Am J Cardiol 2006;97:1374-1376.
31. Strocchi A, Schwartz S, Ellefson M, Engel RR, Medina A, Levitt MD: A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 1992;120:392-399.
32. Shemin D, Rittenberg D: The life span of the human red blood cell. J Biol Chem 1946;166:627-636.
33. Cancelas JA, Dumont LJ, Rugg N, Szczepiorkowski ZM, Herschel L, Siegel A, Pratt PG, Worsham DN, Erickson A, Propst M, North A, Sherman CD, Mufti NA, Reed WF, Corash L: Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process. Transfusion 2011;51:2367-2376.
34. Cancelas JA, Rugg N, Pratt PG, Worsham DN, Pehta JC, Banks K, Davenport RD, Judd WJ: Infusion of P-Capt prion-filtered red blood cell products demonstrate acceptable in vivo viability and no evidence of neoantigen formation. Transfusion 2011;51:2228-2236.
35. Cancelas JA, Rugg N, Fletcher D, Pratt PG, Worsham DN, Dunn SK, Marschner S, Reddy HL, Goodrich RP: In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet lighttreated whole blood. Transfusion 2011;51:1460-1468.
36. Mitlyng BL, Singh JA, Furne JK, Ruddy J, Levitt MD: Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol 2006;81:432-438.
37. Suzuki T, Dale GL: Biotinylated erythrocytes: in vivo survival and in vitro recovery. Blood 1987;70: 791-795.
38. Suzuki T, Dale GL: Senescent erythrocytes: isolation of in vivo aged cells and their biochemical characteristics. Proc Natl Acad Sci USA 1988;85:1647-1651.
39. Suzuki T, Dale GL: Membrane proteins in senescent erythrocytes. Biochem J 1989;257:37-41.
40. Zimran A, Forman L, Suzuki T, Dale GL, Beutler E: In vivo aging of red cell enzymes: study of biotinylated red blood cells in rabbits. Am J Hematol 1990;33:249-254.
41. Dale GL, Norenberg SL: Density fractionation of erythrocytes by percoll/hypaque results in only a slight enrichment for aged cells. Biochim Biophys Acta 1990;1036:183-187.
42. Dale GL, Daniels RB, Beckman J, Norenberg SL: Characterization of senescent red cells from the rabbit; in Magnani M, DeFlora A (eds): Red Blood Cell Aging. New York, NY, Plenum Press, 1991, pp 93-103.
43. Dale GL, Daniels RB: Quantitation of immunoglobulin associated with senescent erythrocytes from the rabbit. Blood 1991;77:1096-1099.
44. Gifford SC, Yoshida T, Shevkoplyas SS, Bitensky MW: A high-resolution, double-labeling method for the study of in vivo red blood cell aging. Transfusion 2006;46:578-588.
45. Lindsell CJ, Franco RS, Smith EP, Joiner CH, Cohen RM: A method for the continuous calculation of the age of labeled red blood cells. Am J Hematol 2008;83:454-457.
46. Christian JA, Rebar AH, Boon GD, Low PS: Senescence of canine biotinylated erythrocytes: increased autologous immunoglobulin binding occurs on erythrocytes aged in vivo for 104 to 110 days. Blood 1993;82:3469-3473.
47. DeJong K, Bhagat A, Emerson RK, Kuypers FA: Flippase activity decreases throughout erythrocyte life-span in normal and sickle mice. ASH 2006;108: abstr 3786.